ArticleThe oncologist2020

Regarding "HER2 Overexpression as a Poor Prognostic Determinant in Resected Biliary Tract Cancer".

Alessandro Rizzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.